Treatment noncompliance with orally disintegrating olanzapine tablets

被引：7
|
作者：
Freudenreich, O
机构：
来源：
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2003年 / 48卷 / 05期
关键词：
D O I：
10.1177/070674370304800521
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：353 / 354
页数：2
相关论文
共 50 条
  • [41] Formulation studies for mirtazapine orally disintegrating tablets
    Yildiz, Simay
    Aytekin, Eren
    Yavuz, Burcin
    Pehlivan, Sibel Bozdag
    Unlu, Nursen
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (06) : 1008 - 1017
  • [42] SUPERDISINTEGRANTS IN THE DEVELOPMENT OF ORALLY DISINTEGRATING TABLETS: A REVIEW
    Pahwa, Rakesh
    Gupta, Nisha
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (11): : 2767 - 2780
  • [43] Tovalt - Zolpidem orally disintegrating tablets - Biovail
    不详
    FORMULARY, 2007, 42 (06) : 361 - 362
  • [44] Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain
    Karagianis, Jamie
    Hoffmann, Vicki Poole
    Arranz, Belen
    Treue, Tamas
    Maguire, Gerald A.
    de Haan, Lieuwe
    Chawla, Bharat
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (04) : 275 - 281
  • [45] Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia (vol 6, pg 97, 2003)
    Kinon, BJ
    Hill, AL
    Liu, H
    Kollack-Walker, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (03): : 313 - 313
  • [46] Olanzapine Orally Disintegrating Tablet: A Review of Efficacy and Compliance
    San, Luis
    Casillas, Marta
    Ciudad, Antonio
    Gilaberte, Inmaculada
    CNS NEUROSCIENCE & THERAPEUTICS, 2008, 14 (03) : 203 - 214
  • [47] Formulation and In-vitro Evaluation of Orally Disintegrating Tablets of Olanzapine-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex
    Shankarrao, Kulkarni Ajit
    Mahadeo, Ghadge Dhairysheel
    Balavantrao, Kokate Pankaj
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2010, 9 (04): : 335 - 347
  • [48] Improvement in influences on medication adherence in non-compliant patients with schizophrenia treated with orally disintegrating olanzapine tablets
    Liu-Seifert, H
    Houston, J
    Hill, A
    Kinon, BJ
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S406 - S406
  • [49] FDA APPROVES LAMOTRIGINE ORALLY DISINTEGRATING TABLETS FOR THE TREATMENT OF BIPOLAR I DISORDER
    Naccari, Christopher
    CNS SPECTRUMS, 2009, 14 (06) : 286 - 286
  • [50] Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets
    Normann, C.
    Schmauss, M.
    Bakri, N.
    Gerwe, M.
    Schreiner, A.
    PHARMACOPSYCHIATRY, 2006, 39 (06) : 209 - 212
12345